1155 related articles for article (PubMed ID: 18566575)
21. Adipocyte differentiation of human marrow mesenchymal stem cells reduces the supporting capacity for hematopoietic progenitors but not for severe combined immunodeficiency repopulating cells.
Ookura N; Fujimori Y; Nishioka K; Kai S; Hara H; Ogawa H
Int J Mol Med; 2007 Mar; 19(3):387-92. PubMed ID: 17273785
[TBL] [Abstract][Full Text] [Related]
22. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
23. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells.
Mayani H; Gutiérrez-Rodríguez M; Espinoza L; López-Chalini E; Huerta-Zepeda A; Flores E; Sánchez-Valle E; Luna-Bautista F; Valencia I; Ramírez OT
Stem Cells; 1998; 16(2):127-35. PubMed ID: 9554037
[TBL] [Abstract][Full Text] [Related]
25. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
[TBL] [Abstract][Full Text] [Related]
26. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.
Kim SK; Koh SK; Song SU; Shin SH; Choi GS; Kim WC; Lee MH; Seoh JY; Park SK; Fraser JK
Mol Cells; 2002 Dec; 14(3):367-73. PubMed ID: 12521299
[TBL] [Abstract][Full Text] [Related]
28. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells.
Panepucci RA; Siufi JL; Silva WA; Proto-Siquiera R; Neder L; Orellana M; Rocha V; Covas DT; Zago MA
Stem Cells; 2004; 22(7):1263-78. PubMed ID: 15579645
[TBL] [Abstract][Full Text] [Related]
31. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
Masuda S; Ageyama N; Shibata H; Obara Y; Ikeda T; Takeuchi K; Ueda Y; Ozawa K; Hanazono Y
Exp Hematol; 2009 Oct; 37(10):1250-1257.e1. PubMed ID: 19638293
[TBL] [Abstract][Full Text] [Related]
32. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Volloch V; Kaplan DL
Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
[TBL] [Abstract][Full Text] [Related]
33. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
[TBL] [Abstract][Full Text] [Related]
34. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
35. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs).
Wan C; He Q; McCaigue M; Marsh D; Li G
J Orthop Res; 2006 Jan; 24(1):21-8. PubMed ID: 16419965
[TBL] [Abstract][Full Text] [Related]
36. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design.
Fan X; Liu T; Liu Y; Ma X; Cui Z
Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963
[TBL] [Abstract][Full Text] [Related]
37. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
39. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent.
Mishima S; Nagai A; Abdullah S; Matsuda C; Taketani T; Kumakura S; Shibata H; Ishikura H; Kim SU; Masuda J
Eur J Haematol; 2010 Jun; 84(6):538-46. PubMed ID: 20088916
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
